- Global incidence and prevalence of nonalcoholic fatty liver disease
-
Teng ML, Ng CH, Huang DQ, Chan KE, Tan DJ, Lim WH, Yang JD, Tan E, Muthiah MD
- KMID: 2539788
- Clin Mol Hepatol.
- 2023 Feb;29(Suppl):S32-S42.
- doi: 10.3350/cmh.2022.0365
Nonalcoholic fatty liver disease (NAFLD) is a leading cause of liver disease worldwide. The estimated global incidence of NAFLD is 47 cases per 1,000 population and is higher among males... -
- CITED
-
- Close
- SHARE
-
- Close
- The effect of diabetes and prediabetes on the prevalence, complications and mortality in nonalcoholic fatty liver disease
-
Ng CH, Chan KE, Chin YH, Zeng RW, Tsai PC, Lim WH, Tan DJH, Khoo CM, Goh LH, Ling ZJ, Kulkarni A, Mak LYL, Huang DQ, Chan M, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M
- KMID: 2531379
- Clin Mol Hepatol.
- 2022 Jul;28(3):565-574.
- doi: 10.3350/cmh.2022.0096
Background/Aims: Nonalcoholic fatty liver disease (NAFLD) is closely associated with diabetes. The cumulative impact of both diseases synergistically increases risk of adverse events. However, present population analysis is predominantly conducted... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals
-
Tang ASP, Chan KE, Quek J, Xiao J, Tay P, Teng M, Lee KS, Lin SY, Myint MZ, Tan B, Sharma VK, Tan DJH, Lim WH, Kaewdech A, Huang D, Chew NW, Siddiqui MS, Sanyal AJ, Muthiah M, Ng CH
- KMID: 2531373
- Clin Mol Hepatol.
- 2022 Jul;28(3):483-496.
- doi: 10.3350/cmh.2021.0406
Background/Aims: Non-alcoholic fatty liver disease (NAFLD) is associated with the development of cardiovascular disease. While existing studies have examined cardiac remodeling in NAFLD, there has been less emphasis on the... -
- CITED
-
- Close
- SHARE
-
- Close
